Our international team of research leaders combine both research expertise and publication know-how. Our team has a shared focus on innovative thinking, which is evident through our dedication to providing clients with the most cutting-edge solutions, services, and ideas available today. Contact us to talk about your research project or ideas.
PhD Molecular Neuroscience, University of Auckland
Dr McGowan was an Associate Editor of Nature Reviews Neuroscience, before joining Edanz in 2006. Prior to
working in the publishing industry, Dr McGowan was a Senior Scientist at the University of Cambridge, UK
and a Marie Curie Research Fellow at the Babraham Institute, also in Cambridge. He has more than ten years
of post-doctoral and post-graduate laboratory experience in the areas of neurodegenerative diseases,
molecular and cellular biology, protein biochemistry, proteomics and genomics. Daniel is a member of ISMPP
and is a Certified Medical Publications Professional.
PhD Molecular Neuroscience, University of Auckland
Our top biostatistician, Dr. Spelman, uses advanced methods to solve clinical epidemiology and health
research problems. He is especially creative, developing novel methods for analyzing time-to-event data
and assessing treatment effects.
PhD Cancer Biochemistry and Cell Biology, University of Cambridge
Dr March is a cancer biologist with special interests in cell signaling, intestinal oncology and cancer
stem cells. Dr March's has focused on the application of innovative models to identify and characterize
novel driver genes in colorectal cancer and is currently a Senior Bioscientist at the Paterson Institute
for Cancer Research in Manchester, UK, where she investigates novel oncology drug targets.
PhD Molecular Neuroscience, University of Auckland
Dr Jelaković is currently a Gastroenterology and Hepatology resident at the University Hospital Center
Zagreb, Croatia, where he is training in cardiology, immunology, hematology, gastroenterology, and
hepatology. His areas of expertise also include biostatistics and epidemiology. He is currently working
toward his PhD in Biomedicine and Health, and his doctoral research is focused on carcinogenesis of
colorectal cancer in patients diagnosed with both primary sclerosing cholangitis and ulcerative colitis.
MD Medicine,
Heidelberg University
Dr Atmanli is a biomedical engineer and physician-scientist with expertise in developmental biology,
tissue engineering, and human pluripotent stem cells. He obtained his PhD from Tufts University and has
since published work in journals including Cell Reports, Development, and Advanced Healthcare Materials.
PhD Molecular Neuroscience, University of Auckland
Dr Iwabuchi has 15 years of research experience in the field of psychology, with specific expertise in
neuroimaging, psychiatry, mental health, and chronic pain. Most recently, she has been involved in a
clinical trial examining the efficacy of transcranial magnetic stimulation in the treatment of depression
using functional MRI, MR spectroscopy, and diffusion-weighted imaging.
